pharma news today glp-1 obesity drug The next phase of the race How Supply and Demand for

Takeaway: The Amylase test is not just a number its a vital diagnostic clue that helps clinicians detect and manage critical digestive and pancreatic conditions early

While lifestyle changes and blood pressure medications remain the foundation of hypertension treatment, the popular weight loss drugs known as GLP-1s are making an impact on how hypertension is managed

Performance of indexed and nonindexed estimated GFR

The incidence of acute pancreatitis, as confirmed by post-marketing monitoring data, are less than 0.1%, which is in line with the rates seen in the general diabetic population

Theres no question too mass or too niche just shoot me an email at [email protected] or add to the comments

Drug makers are currently investigating triple receptor agonist therapies